Top Rx by Sales


Product Name

2014 sales

Treatment for:

Drug manufacturer

 Stock

Company’s hQ

Homepage 

1. Humira

$11.8 billion

Arthritis, psoriasis, bowel diseases

AbbVie

ABBV

United States

 style=border-width: 0px; border-style: solid;

2. Lantus

$10.3 billion

Diabetes

Sanofi

SNY

France

 style=border-width: 0px; border-style: solid;

3. Sovaldi

$9.4 billion

Hepatitis C

Gilead Sciences

GILD

United States

 style=border-width: 0px; border-style: solid;

4. Abilify

$9.3 billion

Serious mental illness

Otsuka Group

OTSKF

Japan

 style=border-width: 0px; border-style: solid;

5. Enbrel

$8.7 billion

Arthritis, psoriasis

Amgen Inc.

AMGN

United States

 style=border-width: 0px; border-style: solid;

6. Crestor

$8.5 billion

High cholesterol

AstraZeneca

AZN

United Kingdom

 style=border-width: 0px; border-style: solid;

7. Remicade

$8.1 billion

Arthritis, psoriasis, bowel diseases

Johnson & Johnson

JNJ

United States

 style=border-width: 0px; border-style: solid;

8. Nexium

$7.7 billion

Acid reflux

AstraZeneca

AZN

United Kingdom

 style=border-width: 0px; border-style: solid;

9. Rituxan/Mabthera

$6.6 billion

Various cancers

The Roche Group

RHHBY

Switzerland

 style=border-width: 0px; border-style: solid;

10. Avastin

$6.1 billion

Various cancers

The Roche Group

RHHBY

Switzerland

 style=border-width: 0px; border-style: solid;

11. Lyrica

$6.0 billion

Nerve disorders

Pfizer Inc.

PFE

United States

 style=border-width: 0px; border-style: solid;

12. Herceptin

$5.6 billion

Various cancers

The Roche Group

RHHBY

Switzerland

 style=border-width: 0px; border-style: solid;

13. Spiriva

$5.5 billion

COPD

The Boehringer Ingelheim Group

 

Germany

 style=border-width: 0px; border-style: solid;

14. Januvia

$5.0 billion

Diabetes

Merck & Co. Inc.

MRK

United States

 style=border-width: 0px; border-style: solid;

15. Copaxone

$4.8 billion

Multiple sclerosis

Teva Pharmaceutical Industries

TEVA

Israel

 style=border-width: 0px; border-style: solid;